$SKFG
Stark Focus Group, Inc.

2024 Q4 Form 10-Q Financial Statement

#000164033424001714 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $5.136K $1.334K
YoY Change 285.01% -106.74%
Operating Profit -$1.205K -$1.334K
YoY Change -9.67% -93.37%
Interest Expense $393.00 $393.00
YoY Change 0.0% -226.77%
% of Operating Profit
Other Income/Expense, Net -$393.00
YoY Change 25.96%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$6.341K -$1.727K
YoY Change 267.17% -91.42%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 9.948M shares 9.948M shares
Diluted Shares Outstanding 9.948M shares 9.948M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $0.00
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $0.00 $0.00
YoY Change -100.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $88.28K $86.72K
YoY Change 1.8% 59.03%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $88.28K $86.72K
Total Long-Term Liabilities
Total Liabilities $127.2K $86.72K
YoY Change 46.68% 59.04%
SHAREHOLDERS EQUITY
Retained Earnings -$170.1K -$129.6K
YoY Change 31.24% 48.09%
Common Stock $995.00 $995.00
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$127.2K -$86.72K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00
YoY Change -100.0%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$6.341K -$1.727K
YoY Change 267.17% -91.42%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Income Loss
NetIncomeLoss
-33740 usd
us-gaap Net Income Loss
NetIncomeLoss
-25317 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q3 us-gaap Assets
Assets
0 usd
CY2023Q4 us-gaap Assets
Assets
0 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
0 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
0 usd
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
71848 usd
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
71848 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
88283 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
87113 usd
CY2024Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
38920 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
6350 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
995 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
995 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
41879 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
41879 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-170077 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-136337 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-127203 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31008 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24150 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2732 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31008 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24183 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
31008 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
24183 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
31008 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24183 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2019Q3 stark Equity Method Investments Ownership Percentage
EquityMethodInvestmentsOwnershipPercentage
1 pure
CY2021Q3 stark Share Issued Under Stock Purchase Agreement
ShareIssuedUnderStockPurchaseAgreement
10000 shares
CY2024Q3 us-gaap Liabilities
Liabilities
127203 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Due to the limited level of operations, the Company has not had to make material assumptions or estimates other than the assumption that the Company is a going concern.</p>
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9948330 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q3 us-gaap Liabilities
Liabilities
127203 usd
CY2023Q4 us-gaap Liabilities
Liabilities
93463 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5136 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1334 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
5136 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1334 usd
us-gaap Operating Expenses
OperatingExpenses
31008 usd
us-gaap Operating Expenses
OperatingExpenses
24150 usd
CY2024Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1205 usd
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
393 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2732 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1167 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-393 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-6341 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1727 usd
us-gaap Financing Interest Expense
FinancingInterestExpense
2732 usd
us-gaap Financing Interest Expense
FinancingInterestExpense
1167 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
393 usd
us-gaap Interest Expense
InterestExpense
1170 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001794942
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9948330 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9948330 shares
CY2021Q3 stark Proceed From Stockpurchase Agreement
ProceedFromStockpurchaseAgreement
10000 hkd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-237100
dei Entity Registrant Name
EntityRegistrantName
STARK FOCUS GROUP INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Address Address Line1
EntityAddressAddressLine1
38 S Federal Highway #10-199
dei Entity Address City Or Town
EntityAddressCityOrTown
Dania Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33004
dei City Area Code
CityAreaCode
352
dei Local Phone Number
LocalPhoneNumber
562 - 0289
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9948330 shares
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
16435 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
15265 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9948330 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-93463 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1205 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1167 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9948330 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9948330 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9948330 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9948330 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-93463 usd
us-gaap Profit Loss
ProfitLoss
-33740 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-127203 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-61403 usd
us-gaap Profit Loss
ProfitLoss
-25317 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-86720 usd
stark Profit And Loss
ProfitAndLoss
33740 usd
stark Profit And Loss
ProfitAndLoss
25317 usd
us-gaap Depreciation
Depreciation
0 usd
us-gaap Depreciation
Depreciation
5967 usd
stark Accounts Payable And Accrued Expenses
AccountsPayableAndAccruedExpenses
0 usd
stark Accounts Payable And Accrued Expenses
AccountsPayableAndAccruedExpenses
6000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
393 usd
us-gaap Interest Expense
InterestExpense
1167 usd

Files In Submission

Name View Source Status
0001640334-24-001714-index-headers.html Edgar Link pending
0001640334-24-001714-index.html Edgar Link pending
0001640334-24-001714.txt Edgar Link pending
0001640334-24-001714-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
stark-20240930.xsd Edgar Link pending
stark_10q.htm Edgar Link pending
stark_ex311.htm Edgar Link pending
stark_ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
stark-20240930_cal.xml Edgar Link unprocessable
stark-20240930_def.xml Edgar Link unprocessable
stark-20240930_lab.xml Edgar Link unprocessable
stark-20240930_pre.xml Edgar Link unprocessable
stark_10q_htm.xml Edgar Link completed